Listed by the USPTO as BARBER, KIMBERLY
Tech Center 3700 • Art Units: 1615 1617 1622 1626 1637 1793 3783
This examiner grants 73% of resolved cases
BARBER, KIMBERLY works in Tech Center 3700 and Art Unit 1615. The record contains 73 resolved cases, a 72.6% allowance rate, and a median of 1095 days to allowance. The case volume is limited, but the allowance figure shows that a majority of recorded matters reached allowance after a material prosecution period.
The interview lift is 19.7%, suggesting a supporting role for interviews. The listed companies are Ch Biotech R&D Co. Ltd., L'Oréal, and Celanese Eva Performance Polymers LLC. The leading firms are Dority & Manning, P.A. and Ticona LLC, ALSTON & BIRD LLP, and BakerHostetler. Counsel should combine application-specific claim analysis with realistic planning for the median timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19101686 | NANOSTRUCTURE, METHOD OF MANUFACTURING NANOSTRUCTURE, FILM, AND STRUCTURE INCLUDING FILM | Non-Final OA | SONY GROUP CORPORATION |
| 18730010 | APATITE FOR FILLER AND FILLER COMPOSITION COMPRISING SAME | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18554928 | OPHTHALMIC FORMULATIONS FOR SUSTAINED NEUROPROTECTION | Non-Final OA | The Johns Hopkins University |
| 18689457 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND INORGANIC UV FILTERS | Final Rejection | BASF SE |
| 18878521 | HERBICIDAL IMIDAZOLE-CONTAINING COMPOUNDS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18577361 | HERBICIDAL COMPOSITIONS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 19056278 | COMPOSITION FOR ENHANCING PLANT GROWTH | Non-Final OA | CH BIOTECH R&D CO., LTD. |
| 18409792 | METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO PROMOTE GROWTH AND DEVELOPMENT OF COTTON SEEDLING | Non-Final OA | CH Biotech R&D Co., Ltd. |
| 18534628 | METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION UPON GRAPE PLANTS TO INCREASE PRODUCTION YIELD | Non-Final OA | CH Biotech R&D Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy72.6% of resolved applications examined by Kimberly Barber were allowed (73 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +19.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kimberly Barber took 1,095 days on average from filing to allowance.
Kimberly Barber examines applications in Art Unit 1615 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
